计算溶液所需的质量、体积或浓度。
This is a demo store. No orders will be fulfilled.
| 货号 (SKU) | 包装规格 | 是否现货 | 价格 | 数量 |
|---|---|---|---|---|
| I132661-1mg |
1mg |
现货 ![]() |
| |
| I132661-5mg |
5mg |
现货 ![]() |
| |
| I132661-25mg |
25mg |
现货 ![]() |
|
| 英文别名 | BSPBio_001108 | UNII-X6CSG51MBQ | BDBM54681 | BCBcMAP01_000150 | HBDSHCUSXQATPO-BGBJRWHRSA-N | Indirubin 3'-monoxime | Indirubin-3monoxime | INDIRUBIN-3'-MONOXIME | Indirubin-3-monoxime | AC-30025 | Indirubin-3??-oxime | EU-0100619 | FQCPPVRJPILDIK-UHFFFA |
|---|---|
| 规格或纯度 | Moligand™, ≥98%(HPLC) |
| 英文名称 | Indirubin-3′-oxime |
| 生化机理 | 吲哚鲁宾-3′-肟是一种细胞周期蛋白依赖性激酶抑制剂,其作用是与 ATP 竞争与催化亚基的结合;具有抗增殖活性,可导致许多细胞系的 G2/M 停滞,以及 Jurkat 细胞的 G1/S 停滞。CDK 抑制剂(IC 50 值分别为 0.1(Cdk5/p35)、0.18(Cdk1/细胞周期蛋白 B)、0.25(Cdk2/细胞周期蛋白 E)、0.5(Cdk2/细胞周期蛋白 A)和 3.3 μM(Cdk4/细胞周期蛋白 D1))。通过 G 2 /M 细胞周期停滞显示出可逆的抗增殖效应。 |
| 运输条件 | 常规运输 |
| 作用类型 | 抑制剂 |
| 作用机制 | 糖原合酶激酶 3 beta 抑制剂 |
| 备注 | 如果有可能,您尽量在使用的当天配置溶液,并在当天使用完它。但是,如果您需要预先配制储备溶液,我们建议您将溶液等份保存在-20°C的密封小瓶中。通常,它们最多可以使用一个月。在使用前和打开样品瓶之前,我们建议您让您的产品在室温下平衡至少1小时。需要更多关于溶解度,用法和处理的建议吗?请访问我们的常见问题(FAQ)页面以获取更多详细信息。 |
| 产品介绍 |
Indirubin-3'-monoxime is a potent inhibitor of GSK-3β (IC50=22 nM)1. Indirubin-3'-monoxime also inhibits CDK1 (p34cdc2; IC50=180 nM) and CDK5 (IC50=100 nM)1. Indirubin-3'-monoxime reversibly arrests asynchronous HBL-100 cells at G22. This compound induces apoptosis in the mammary carcinoma cell line MCF-7 (10 μM). Indirubin-3'-monoxime is an inhibitor of Cdk2, cyclin A, cyclin B, cyclin E and p35.A potent inhibitor of GSK-3β, Cdk1, and Cdk5 Indirubin-3'-monoxime is a potent inhibitor of GSK-3β (IC50=22 nM)1. Indirubin-3'-monoxime also inhibits CDK1 (p34cdc2; IC50=180 nM) and CDK5 (IC50=100 nM)1. Indirubin-3'-monoxime reversibly arrests asynchronous HBL-100 cells at G22. This compound induces apoptosis in the mammary carcinoma cell line MCF-7 (10 μM). Indirubin-3'-monoxime is an inhibitor of Cdk2, cyclin A, cyclin B, cyclin E and p35. |
| 纯度 | ≥98%(HPLC) |
| PubChem SID | 504750702 |
|---|---|
| 分子类型 | 小分子 |
| IIUPAC Name | 3-(3-nitroso-1H-indol-2-yl)-1H-indol-2-ol |
| INCHI | 1S/C16H11N3O2/c20-16-13(9-5-1-3-7-11(9)18-16)15-14(19-21)10-6-2-4-8-12(10)17-15/h1-8,17-18,20H |
| InChi Key | FQCPPVRJPILDIK-UHFFFAOYSA-N |
| Smiles | C1=CC=C2C(=C1)C(=C(N2)O)C3=C(C4=CC=CC=C4N3)N=O |
| Isomeric SMILES | C1=CC=C2C(=C1)C(=C(N2)O)C3=C(C4=CC=CC=C4N3)N=O |
| 分子量 | 277.28 |
| Reaxy-Rn | 33446338 |
| Reaxys-RN link address | https://www.reaxys.com/reaxys/secured/hopinto.do?context=S&query=IDE.XRN=33446338&ln= |
| 溶解性 | Soluble in DMSO (6 mg/ml), ethanol (4 mg/ml), DMF (~10 mg/ml), 1:5 DMSO:PBS (pH 7.2) (0.15 mg/ml), and methanol. Insoluble in water. |
|---|---|
| 分子量 | 277.280 g/mol |
| XLogP3 | 3.200 |
| 氢键供体数Hydrogen Bond Donor Count | 3 |
| 氢键受体数Hydrogen Bond Acceptor Count | 3 |
| 可旋转键计数Rotatable Bond Count | 1 |
| 精确质量Exact Mass | 277.085 Da |
| 单同位素质量Monoisotopic Mass | 277.085 Da |
| 拓扑极表面积Topological Polar Surface Area | 81.200 Ų |
| 重原子数Heavy Atom Count | 21 |
| 形式电荷Formal Charge | 0 |
| 复杂度Complexity | 405.000 |
| 同位素原子数Isotope Atom Count | 0 |
| 定义的原子立体中心计数Defined Atom Stereocenter Count | 0 |
| 未定义的原子立体中心计数Undefined Atom Stereocenter Count | 0 |
| 定义的键立体中心计数Defined Bond Stereocenter Count | 0 |
| 未定义的键立体中心计数Undefined Bond Stereocenter Count | 0 |
| 所有立体化学键的总数The total count of all stereochemical bonds | 0 |
| 共价键合单元计数Covalently-Bonded Unit Count | 1 |
| WGK Germany | 3 |
|---|---|
| 个人防护装备 | Eyeshields, Gloves, type N95 (US), type P1 (EN143) respirator filter |
| 1. Leclerc S, Garnier M, Hoessel R, Marko D, Bibb JA, Snyder GL, Greengard P, Biernat J, Wu YZ, Mandelkow EM et al.. (2001) Indirubins inhibit glycogen synthase kinase-3 beta and CDK5/p25, two protein kinases involved in abnormal tau phosphorylation in Alzheimer's disease. A property common to most cyclin-dependent kinase inhibitors?. J Biol Chem, 276 (1): (251-60). [PMID:11013232] |
| 2. Christ W et al.. (2020) Puumala and Andes Orthohantaviruses Cause Transient Protein Kinase R-Dependent Formation of Stress Granules.. J Virol, 94 (3): [PMID:31723021] |
| 3. Liu Shou Gang, Luo Guang Pu, Qu Yong Bin, Chen Yong Feng. (2020) Indirubin inhibits Wnt/β-catenin signal pathway via promoter demethylation of WIF-1. BMC Complementary Medicine and Therapies, 20 (1): (1-10). [PMID:32795328] [10.1186/s12906-020-03045-9] |